Sb Investment Advisers (Uk) LTD Roivant Sciences Ltd. Transaction History

Sb Investment Advisers (Uk) LTD

$11 Billion
Q1 2025

A detailed history of Sb Investment Advisers (Uk) LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 61,852,718 shares of ROIV stock, worth $711 Million. This represents 5.69% of its overall portfolio holdings.

Number of Shares

61,852,718

Previous 62,057,537 0.33%

Holding current value

$711 Million

Previous $734 Million 14.99%

% of portfolio

5.69%

Previous 6.45%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$10.09 - $12.08 $2.07 Million - $2.47 Million	-204,819 Reduced 0.33%	61,852,718 $624 Million
Q4 2024 Feb 14, 2025	SELL	$11.16 - $12.71 $43.3 Million - $49.3 Million	-3,876,537 Reduced 5.88%	62,057,537 $734 Million
Q3 2024 Nov 14, 2024	SELL	$10.17 - $12.5 $55.2 Million - $67.8 Million	-5,427,314 Reduced 7.61%	65,934,074 $761 Million
Q2 2024 Aug 14, 2024	SELL	$10.36 - $11.74 $17.3 Million - $19.6 Million	-1,670,279 Reduced 2.29%	71,361,388 $754 Million
Q3 2023 Nov 14, 2023	SELL	$9.76 - $13.19 $97.6 Million - $132 Million	-10,000,000 Reduced 12.04%	73,031,667 $853 Million
Q1 2023 May 15, 2023	SELL	$6.92 - $9.98 $83 Million - $120 Million	-12,000,000 Reduced 12.63%	83,031,667 $613 Million
Q4 2022 Feb 14, 2023	SELL	$3.36 - $7.99 $14.6 Million - $34.7 Million	-4,343,919 Reduced 4.37%	95,031,667 $759 Million
Q4 2021 Feb 14, 2022	BUY	$5.86 - $13.52 $582 Million - $1.34 Billion	99,375,586 New	99,375,586 $1 Billion

Others Institutions Holding ROIV

# of Institutions

332

Shares Held

496M

Call Options Held

3.67M

Put Options Held

754K

View Full List

About Roivant Sciences Ltd.

Ticker ROIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 704,382,976
Market Cap $8.1B
Description
Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...

More about ROIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sb Investment Advisers (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sb Investment Advisers (Uk) LTD with notifications on news.

Account

Sb Investment Advisers (Uk) LTD Roivant Sciences Ltd. Transaction History